Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

ASCO 2015 Oncology Meeting Is Underway

Our first report from the 2015 annual meeting of the American Society of Clinical Oncology covers a possibly practice-changing study on surgery in early-stage breast cancer, and a novel treatment to prevent hair loss caused by chemotherapy.

Side Effects Greater for Some Given Tamoxifen With Ovarian Suppression

A study looking at differences between tamoxifen-only treatment and tamoxifen plus ovarian function suppression, or OFS, in certain premenopausal women with early-stage breast cancer, found the OFS group experienced more difficulty with menopausal symptoms and other side effects. 

Updates from San Antonio Breast Cancer Symposium

Highlights from the annual San Antonio Breast Cancer Symposium held December 9-13, 2014 including presentation of results from a new survey conducted by Living Beyond Breast Cancer on the psychosocial needs of women with triple-negative breast cancer. 

Better Access to Surgery Information May Improve Reconstruction Decision Making

An article published in JAMA Surgery suggests that even while some state laws are mandating changes in the way doctors discuss the safety of breast implants and the pros and cons of having immediate or delayed reconstruction, gaps in education still remain.

ASCO Updates Guideline on Length of Tamoxifen Treatment

After evaluating long-term results from recent studies, the American Society of Clinical Oncology, ASCO, issued a guideline update for tamoxifen therapy for hormone receptor-positive breast cancer.

The update advises doctors to offer up to 10 years of tamoxifen treatment, instead of the previous standard 5-year duration

ASCO Breast Reports on Recurrence after Early Chemotherapy

LBBC highlights a study reported on the first day of the American Society of Clinical Oncology 2014 Breast Cancer Symposium: an analysis of breast cancer recurrence rates after pre-surgery, or neoadjuvant, chemotherapy.

Researchers Identify Barriers to Early-Stage Breast Cancer Treatment

Although more women are having lumpectomies, an evaluation of data in the National Cancer Database found socioeconomic barriers prevent some from choosing this surgery. Meeghan Ann Lautner, MD, of the University of Texas San Antonio, announced findings at the American Society of Clinical Oncology 2014 Breast Cancer Symposium on September 4.

Experts Discuss New Guideline for Margins in Breast-Conserving Surgery

A panel of experts reviewed key points and limitations of a new national guideline on margins for lumpectomy, also called breast-conserving surgery, at the American Society of Clinical Oncology 2014 Breast Cancer Symposium in San Francisco on September 4, 2014. They also discussed how it can be used in clinical practice.

Women With Young Children Less Likely to Receive Radiation Therapy

Having very young children may affect whether women receive radiation therapy after breast-conserving surgery.

ASCO Releases Updated Sentinel Lymph Node Biopsy Guidelines

The American Society of Clinical Oncology published updates to their 2005 guidelines for use of sentinel lymph node biopsy in early-stage breast cancer. The guidelines, based on the review of 9 randomized clinical trials and 13 cohort studies, reflect what ASCO believes are best practices in using the biopsy.